Top Banner
Newborn Screening Ideally, your baby undergoes Newborn Screening (NBS) within three days of his birth. NBS will be able to tell if your baby was born with any metabolic disorders that will affect his body's normal processes and functions. What is my baby being screened for? Currently, NBS tests for five disorders: Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency A condition where the body lacks the enzyme called G6PD. The deficiency may cause hemolytic anemia, when the body is exposed to oxidative substances found in certain drugs, foods and chemicals. Parents of G6PD-positive babies receive a list of these substances from their doctor. While this is the mildest disorder that is covered in NBS, it is the most common: One out of 55 babies may be affected. Read more in our article on G6PD deficiency. Congenital Hypothyroidism This is a lack of thyroid hormone, which your baby needs to grow. Treatment is required within the first four weeks of a baby's life to prevent stunted physical growth and mental retardation. One out of 3,369 babies is at risk. Congenital Adrenal Hyperplasia An endocrine disorder that causes severe salt loss, dehydration and abnormally high levels of male sex hormones. Left undetected and untreated, it can be fatal within seven to 14 days. One in 7,960 babies is at risk. Galactosemia A condition in which babies cannot process the sugar present in milk (galactose). This
14
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Newborn Screening

Newborn Screening

Ideally, your baby undergoes Newborn Screening (NBS) within three days of his birth. NBS will be able to tell if your

baby was born with any metabolic disorders that will affect his body's normal processes and functions. 

What is my baby being screened for? 

Currently, NBS tests for five disorders: 

• Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency 

A condition where the body lacks the enzyme called G6PD. The deficiency may cause hemolytic anemia, when the

body is exposed to oxidative substances found in certain drugs, foods and chemicals. Parents of G6PD-positive

babies receive a list of these substances from their doctor. 

While this is the mildest disorder that is covered in NBS, it is the most common: One out of 55 babies may be

affected. Read more in our article on G6PD deficiency. 

• Congenital Hypothyroidism 

This is a lack of thyroid hormone, which your baby needs to grow. Treatment is required within the first four weeks of

a baby's life to prevent stunted physical growth and mental retardation. One out of 3,369 babies is at risk. 

• Congenital Adrenal Hyperplasia 

An endocrine disorder that causes severe salt loss, dehydration and abnormally high levels of male sex hormones.

Left undetected and untreated, it can be fatal within seven to 14 days. One in 7,960 babies is at risk. 

• Galactosemia 

A condition in which babies cannot process the sugar present in milk (galactose). This leads to increased galactose

levels in the body, which leads to liver and brain damage. It also causes cataracts to develop. One in 82,250 babies

may be affected. 

• Phenylketonuria 

Page 2: Newborn Screening

A condition where the body does not properly use the enzyme phenylalanine, which may lead to brain damage. One

in 109,666 babies may be at risk. 

Is it really necessary to screen my baby? 

It is crucial that these disorders are detected as early as possible. An affected baby looks healthy at birth because

symptoms do not begin to show until weeks or months later. Once the signs and symptoms set in, the ill effects are

often already permanent. If these conditions are left untreated, they may cause health complications or inhibit mental

development. In the most serious cases, they can cause death. 

The Philippine Newborn Screening Project says that 33,000 children out of the two million Filipino babies born yearly

are at risk from these disorders. 

Fortunately, children diagnosed with any of these disorders can continue to live normal and healthy lives as long as

they are treated in time and they consistently follow up with a specialist. 

How is Newborn Screening administered? 

Your baby will be pricked at the heel. Three drops of blood will be taken for testing. 

A negative screen means that results are normal. A positive screen will require the baby to undergo further testing by

a pediatrician. Parents are oriented about their child’s condition through the National Institutes of Health (at the

Philippine General Hospital). Parents will be notified through mail and through their attending doctors about positive

results, and will be required to undergo the orientation and further testing at the NIH. 

Is NBS compulsory? 

The Department of Health and other health organizations strongly recommend that all babies undergo Newborn

Screening. Most tertiary centers are accredited Newborn Screening testing centers. If a baby is delivered at home or

in a primary health care setting or lying in, the baby can be brought to the nursery of any accredited center after the

48th hour of life for testing (on out - patient basis). 

Sometimes, parents decline for various reasons, such as religious concerns. In these cases, they are asked to

Page 3: Newborn Screening

acknowledge in writing that they understand the benefits of NBS and that they know they may be placing their

newborn at risk for undiagnosed congenital conditions by declining the test. This dissent form is included in the

baby's medical record and is recorded in the National Newborn Screening Database. 

Newborn Screening

Print Email PDF

 

Republic Act 9288

 

Newborn screening (NBS) is a public health program aimed at the early identification of infants who are

affected by certain genetic/metabolic/infectious conditions. Early identification and timely intervention can

lead to significant reduction of morbidity, mortality, and associated disabilities in affected infants. NBS in the

Philippines started in June 1996 and was integrated into the public health delivery system with the

enactment of the Newborn Screening Act of 2004 (Republic Act 9288). From 1996 to December 2010, the

program has saved 45 283 patients.   Five conditions are currently screened: Congenital Hypothyroidism,

Congenital Adrenal Hyperplasia, Phenylketonuria, Galactosemia, and Glucose-6-Phosphate Dehydrogenase

Deficiency.  

 

 

Page 4: Newborn Screening

Current Status of NBS Implementation in the Philippines

 

Newborn Screening Legislation

NBS was integrated into the public health delivery system with the enactment of Republic Act 9288 or

Newborn Screening Act of 2004   as it institutionalized the ‘National NBS System’, which shall ensure the

following: [a] that every baby born in the Philippines is offered NBS; [b] the establishment and integration of

a sustainable NBS System within the public health delivery system; [c] that all health practitioners are aware

of  the benefits of NBS and of their responsibilities in offering it; and [d] that all parents are aware of NBS

and their responsibility in protecting their child from any of the disorders. The highlights of the law and its

implementing rules and regulations are:

 

1. DOH is the lead agency tasked with implementing this law;2. Any health practitioner who delivers or assists in the delivery of a newborn in the Philippines shall prior

to delivery, inform parents or legal guardians of the newborns the availability, nature and benefits of NBS;

3. Health facilities shall integrate NBS in its delivery of health services;4. Creation of the Newborn Screening Reference Center at the National Institutes of Health and

establishment and accreditation of NSCs equipped with a NBS laboratory and recall/follow up program;5. Provision of  NBS services as a requirement for licensing and accreditation, the DOH and the Philippine

Health Insurance Corporation (PHIC)6. Inclusion of cost of NBS in insurance benefits

 

Currently, there are four Newborn Screening Centers (NSCs) in the country: NSC-National Institutes of Health

in Manila; NSC- Visayas in Iloilo City; NSC-Mindanao in Davao City; and NSC-Central Luzon in Angeles City.

The four NSCs provide laboratory and follow up services for more than 3000+ health facilities.

 

DOH, its partners and major stakeholders remain aggressive in identifying strategies to intensify awareness

in the communities and increase coverage among home deliveries.  Among the recent efforts to increase the

newborn screening coverage are appointment of full-time Regional NBS Coordinators; opening more G6PD

Confirmatory Laboratories; partnership with midwives organizations; and production of information materials

targeting different groups of health workers and professionals.

 

Key Players in the Implementation

 

Organizational chart for the national implementation of Newborn Screening

Page 5: Newborn Screening

 

Newborn Screening Statistics  

As of December 2010, there are 2,389,959 babies that have undergone NBS and based on these data, the

incidences of the following disorders are: CH (1: 3,324); CAH (1: 9,446); PKU (1: 149,372); Gal (1: 108,635)

and G6PD deficiency (1: 52).  The program has saved the following numbers of newborns from complications

and/or death:  719 from CH, 253 from CAH, 22 from Gal, 16 from PKU and 44 273 from G6PD deficiency.

 

Coverage

As of December 2010, the coverage of NBS is at 35%.  

 

 

Page 6: Newborn Screening

DIRECTORY OF PROGRAM IMPLEMENTERS

 

National Center for Disease Prevention and Control –Family Health Office

Program Manager

Dr. Juanita A. Basilio

Dr. Anthony P. Calibo

 

National Newborn Screening Coordinator:

Ms. Lita Orbillo

San Lazaro Compound, Sta. Cruz, Manila

Telephone: (02) 7359956 

[email protected]  

 

Newborn Screening Reference Center

Director: Dr. Carmencita D. Padilla 

National Institutes of Health

Building H, UP Ayala Land Technohub

Complex,Commonwealth Avenue, Brgy. UP Campus

Diliman, Quezon City

Email: [email protected]

www.newbornscreening.ph 

 

Newborn Screening Centers

 

For Regions I, II, III & CAR 

Unit Head: Dr. Florencio Dizon

Newborn Screening Center – Central Luzon

Angeles City University Foundation Medical Center 

MacArthur Highway, Barangay Salapungan, Angeles City

Telephone: (045) 6246502-03; Email: [email protected]

Page 7: Newborn Screening

 

For Regions IV, V & NCR 

Newborn Screening Center– National Institutes of Health 

Unit Head: Ms. Ma. Elouisa Reyes

Building H, UP Ayala Land Technohub

Complex,Commonwealth Avenue, Brgy. UP Campus

Diliman, Quezon City

Email: [email protected]

 

For Visayas  

Newborn Screening Center– Visayas

Unit Head: Dr. J Winston Edgar Posecion

West Visayas State University Medical Center

E. Lopez St., Jaro, Iloilo City

Telefax: (033) 329-3744; Email: [email protected]

 

For Mindanao  

Newborn Screening Center– Mindanao

Unit Head: Dr. Conchita Abarquez

Southern Philippines Medical Center

J.P. Laurel Avenue, Davao City

Telephone: (082) 226-4595 / 224-0337 

Telefax (082) 227-4152; Email:[email protected]

 

Centers for Health Development

 

 

CHD Mailing Address Business PhoneNBS Regional Coordinator

Page 8: Newborn Screening

CHD 1 - Ilocos San Fernando, La Union(072) 2425315; (072) 2424773

Clarita B. Lewis, RN

CHD 2 - Cagayan Valley

Tuguegarao City(078) 3046585; (078) 8446585; (078) 8446523

Leticia T. Cabrera, MD, MPA

CHD 3 - Central Luzon

San Fernando, Pampanga(045) 4552324; (045) 9617649; (045) 9617654

Adelina Cabrera, RN

CHD 4-A Calabarzon

QMMC Compound, Project 4, Quezon City

(02) 4403372Maria Luisa M. Malana, RN

CHD 4-B Mimaropa

Quirino Hospital Compound, Quezon City

(02) 9134650; (02) 9115025

Ma. Teresa Castillo, MD

CHD 5- BicolFirst Park Subdidivion, Daraga, Albay

(052) 4830840loc 517/516

Carla A. Orozco, MD, MPHMS III

CHD 6 - Western Visayas

Q. Abeto St., Mandurriao, Iloilo City

(033)3210364Renilyn P. Reyes, MD

CHD 7 - Central Visayas

Osmeña Blvd., Cebu City (032) 4187633Nayda P. Bautista,MD, MPH

CHD 8- Eastern Visayas

Candahug, Palo , Leyte (053)3235025Lilibeth Andrade, MD

CHD 9 - Zamboanga Peninsula

Upper Calarian, Zamboanga City

(062)9830314-15Nerissa B. Gutierrez, RN

CHD 10 - Northern Mindanao

J.V. Seriña St., Carmen, Cagayan de Oro City

088-22- 727400Ellenietta HMV N. Gamolo, MD, MPH

Page 9: Newborn Screening

CHD 11 - Davao Region

J.P. Laurel Avenue, Davao City

(082) 3051907; (082) 2214011

Ma. Clarose M. Mascardo, RN, MPH

CHD 12 - Central Mindanao

ARMM Compound, Gov. Guttierez Ave, Cotabato City

(064) 4217436; (064) 4218053

Lucy Decio, RN

CHD CARAGAPizarro St. cor. Narra Rd. Butuan City

(085) 3411452Glynna B. Andoy, MD, MPH

CHD CARBGHMC Compound, Baguio City

(074) 4428096; (074) 4445255

Nicolas R. Gordo, Jr, MD

CHD NCRWelfareville Compound, Brgy. Addition Hills, Mandaluyong City

(02) 7183097; (02) 5354521

Ma. Paz P. Corrales, MD

CHD ARMMORG Compound, Cotabato City

(064) 4217703Dayan Sangcopan, MD

Reunion of Saved Babies, October 10, 2010 at the UP Bahay ng Alumni, Quezon City

 

Newborn Screening Poster

Page 10: Newborn Screening

 

 

Page 11: Newborn Screening

Continuing Education for Health Professionals, October 4, 2011 in La Union

 

 

The Heel Prick Method

 

 

NBS Awarding Ceremony

October 3, 2011

Page 12: Newborn Screening

Traders Hotel